China Aoxing Completes Trial of Pain Drug

China Aoxing Pharmaceutical Company has completed its Phase III trial of Tilidine tablets, an synthetic oral narcotic drug that treats acute and chronic moderate to severe pain, including post-operative and cancer pain. The drug, which is not currently available in China, is a Class III New Medicine that will enjoy at least four years of market exclusivity protection, post-approval. More details... Stock Symbol: (OTCBB: CAXG)